The median 1-year healthcare costs of a patient with intracerebral hemorrhage (ICH) is US$26,886 (IQR 9,641–62,907), which is 10 times that of the median in-patient cost.
Why this matters
Investigating the direct costs of disease helps governments to allocate healthcare resources and prioritize patient outcomes effectively.
The management and outcomes of ICH are well-known but understanding of healthcare costs is limited. It is known that people with ICH have high in-hospital costs, typically a result of prolonged stays in intensive care, while prolonged rehabilitation means healthcare costs can continue to mount after discharge. Having an accurate picture of these costs is important for future allocation of healthcare resources.